The Cooper Companies, Inc. (NASDAQ:COO) Given Average Recommendation of “Hold” by Brokerages

The Cooper Companies, Inc. (NASDAQ:COO) has been given a consensus recommendation of “Hold” by the sixteen research firms that are presently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $81.3077.

A number of brokerages have issued reports on COO. Rothschild & Co Redburn lowered Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price on the stock. in a research report on Wednesday, March 4th. Robert W. Baird cut their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the stock an “overweight” rating in a research report on Monday, June 1st. BNP Paribas Exane dropped their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research note on Monday, June 8th. Finally, The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research note on Wednesday, May 27th.

Institutional Trading of Cooper Companies

Several institutional investors and hedge funds have recently made changes to their positions in COO. Wellington Management Group LLP grew its position in Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after purchasing an additional 4,756,178 shares during the last quarter. Generation Investment Management LLP purchased a new position in Cooper Companies during the 4th quarter worth $233,539,000. Diamond Hill Capital Management Inc. raised its stake in shares of Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after purchasing an additional 2,720,594 shares during the last quarter. JANA Partners Management LP purchased a new stake in shares of Cooper Companies during the third quarter worth approximately $166,917,000. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Trading Down 3.4%

Shares of COO stock opened at $65.05 on Thursday. The stock’s fifty day moving average is $64.58 and its two-hundred day moving average is $74.10. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The firm has a market capitalization of $12.69 billion, a P/E ratio of 55.13, a PEG ratio of 1.76 and a beta of 0.87. Cooper Companies has a fifty-two week low of $58.89 and a fifty-two week high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period in the prior year, the business earned $0.96 earnings per share. The business’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts expect that Cooper Companies will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.